Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 10124122 was granted and assigned to Vetter Pharma on November, 2018 by the United States Patent and Trademark Office. | 10124122 | November 13, 2018 | |||||||
Patent 11446206 was granted and assigned to Vetter Pharma on September, 2022 by the United States Patent and Trademark Office. | 11446206 | September 20, 2022 | |||||||
Patent 9764098 was granted and assigned to Vetter Pharma on September, 2017 by the United States Patent and Trademark Office. | 9764098 | September 19, 2017 | |||||||
Patent 11400020 was granted and assigned to Vetter Pharma on August, 2022 by the United States Patent and Trademark Office. | 11400020 | August 2, 2022 | |||||||
Patent 9925340 was granted and assigned to Vetter Pharma on March, 2018 by the United States Patent and Trademark Office. | 9925340 | March 27, 2018 | |||||||
11439755 | September 13, 2022 | ||||||||
Patent D834709 was granted and assigned to Vetter Pharma on November, 2018 by the United States Patent and Trademark Office. | D834709 | November 27, 2018 | |||||||
Patent D840532 was granted and assigned to Vetter Pharma on February, 2019 by the United States Patent and Trademark Office. | D840532 | February 12, 2019 | |||||||
Patent 10940037 was granted and assigned to Vetter Pharma on March, 2021 by the United States Patent and Trademark Office. | 10940037 | March 9, 2021 | |||||||
Patent 10583253 was granted and assigned to Vetter Pharma on March, 2020 by the United States Patent and Trademark Office. | 10583253 | March 10, 2020 | |||||||
Patent D850612 was granted and assigned to Vetter Pharma on June, 2019 by the United States Patent and Trademark Office. | D850612 | June 4, 2019 | |||||||
Patent 10357611 was granted and assigned to Vetter Pharma on July, 2019 by the United States Patent and Trademark Office. | 10357611 | July 23, 2019 | |||||||
Patent D834708 was granted and assigned to Vetter Pharma on November, 2018 by the United States Patent and Trademark Office. | D834708 | November 27, 2018 | |||||||
Patent D933508 was granted and assigned to Vetter Pharma on October, 2021 by the United States Patent and Trademark Office. | D933508 | October 19, 2021 | |||||||
Patent 10195111 was granted and assigned to Vetter Pharma on February, 2019 by the United States Patent and Trademark Office. | 10195111 | February 5, 2019 | |||||||
Patent 10695493 was granted and assigned to Vetter Pharma on June, 2020 by the United States Patent and Trademark Office. | 10695493 | June 30, 2020 | |||||||
Patent 11160930 was granted and assigned to Vetter Pharma on November, 2021 by the United States Patent and Trademark Office. | 11160930 | November 2, 2021 |